发明名称 Selected cell delivery for heart failure
摘要 This invention provides methods of increasing blood flow to tissue in a subject in need thereof, methods of regenerating tissue in a subject, methods of treating diseased tissue in a subject, methods of forming new blood vessels in tissue and new tissue, such as myocardial tissue, in a subject in need thereof, methods of increasing angiogenesis in diseased tissue in a subject, and methods of preventing heart failure in a subject, which methods comprise: a) isolating autologous mononuclear cells from the subject; b) selecting from the isolated autologous mononuclear cells of step (a) lineage negative (Lin<->) mononuclear cells; and c) transplanting locally into or adjacent to the tissue an effective amount of the Lin<-> autologous mononuclear cells, resulting in formation of new blood vessels in the tissue and formation of new tissue. Additional methods provided for such uses further select from the isolated autologous mononuclear cells of step (a) lineage negative (Lin<->) mononuclear cells a subset of Lin<-> mononuclear side population (SP) cells and transplant locally into or adjacent to the tissue an effective amount of the Lin<-> SP cells. In other aspects, methods using tissue other than mononuclear cells for these uses are provided, which comprise (a) obtaining a cell suspension from the tissue or a second tissue of the subject; (b) selecting from the cell suspension step (a) side population (SP) cells; and (c) transplanting locally into or adjacent to the tissue an effective amount of the SP cells, resulting in formation of new blood vessels in the tissue and formation of new tissue.
申请公布号 US2004014213(A1) 申请公布日期 2004.01.22
申请号 US20020198101 申请日期 2002.07.19
申请人 FREYMAN TOBY 发明人 FREYMAN TOBY
分类号 A61K35/14;A61K35/28;A61P9/10;C12N5/02;(IPC1-7):C12N5/02;C12N5/00 主分类号 A61K35/14
代理机构 代理人
主权项
地址